CLYM

Climb Bio, Inc.

Contracts

Total Value

Stock Metrics

25.1%

Short % Float

6.8d to cover · High squeeze

88.8%

Inst % Float

10 holders · 2026-06-30

RA Capital Managem

Top Holder

19.7% of float

28.1M sh

Public Float

53/100

Dilution Score

High

28 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

53/100

HIGH

Inst: 88.76% · Top: RA Capital Management, L.P.

Biotech Analytics

Biotech / Pharma

39.09

Dilution Risk: HIGHSqueeze risk: HIGHBiotech Grade: D

Insider Buying0

Publications50

Dilution Risk53

Clinical Trials54

Short Interest70